The staff and clients of Innovacorp welcome our newest client, Skillz Systems.

Innovacorp’s president and CEO is now lending his business expertise to companies across the country, advising them on how they can enhance their operations and strategies.

The staff and clients of Innovacorp welcome our newest client, Clearly Health.

Innovacorp is a proud sponsor of this year’s Acadia Challenge Proof of Concept competition.

The staff and clients of Innovacorp welcome our newest client, Marsco Technologies.

ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, announced today the appointment of former senator, Michael Kirby, as the new board of directors chair. Michael Kirby succeeds the late Dr. Warrick Kimmins, who provided exemplary leadership during his tenure and was instrumental in spinning out IVT’s novel technology from Dalhousie University.

An intense five-month competition came to an end Tuesday evening as Innovacorp announced the provincial winner of the I-3 Technology Start-Up Competition. MorSwift Machines Inc. from Digby NS, was awarded a $100,000 seed equity investment from Innovacorp.

Check out some images from Innovacorp's I-3 Technology Start-Up Competition awards event - February 12, 2008.

ImmunoVaccine Technologies Inc. (IVT) announced today that it has met with Health Canada’s regulatory affairs division, the Biologics and Genetic Therapies Directorate, to discuss requirements for a Phase I clinical trial application. For Phase I human clinical trials, IVT plans to combine novel antigens with its vaccine-enhancement technology, the VacciMax® platform.

EastMed Inc., a medical manufacturing company that caters specifically to women's health and wellness, welcomes two new members to its team: James Lodigiani, CEO, and Jeff Smith, chairman of the board.